Intestinal transcriptomics, serum metabolomics, and lipidomics data indicated that the synergy of specific B. bifidum strains to anti-PD-1 is closely related to IFN-γ, because IFNγR blockade eliminates the tumor reduction effect of anti-PD-1 plus B. bifidum. The gene discussed is IFNG; the disease is neoplasm.